Comparison of Efficacy and Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors as Add-On Therapy in Patients With Type 2 Diabetes

Background Type 2 diabetes is a chronic metabolic disorder that is escalating at an alarming rate worldwide. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are recent oral antihyperglycemic drugs (OADs) with a unique mechanism of action. Objectives This study aimed compared the efficacy and safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Mazhar, Elahi, Asim, Iqbal, Javed, Bilal Ghafoor, Muhammad, Rehman, Habib, Akhtar, Shoaib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090899/
https://www.ncbi.nlm.nih.gov/pubmed/33954073
http://dx.doi.org/10.7759/cureus.14268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090899/
https://www.ncbi.nlm.nih.gov/pubmed/33954073
http://dx.doi.org/10.7759/cureus.14268

Ejemplares similares